Olopatadine Hydrochloride 80539-0001-39
- Manufacturer
- Allwell Health Inc
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- July 15, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA209995
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Inhibitor [EPC]
Selected Package
80539-0001-39Selected1 BOTTLE, PLASTIC in 1 CARTON (80539-001-39) / 2.5 mL in 1 BOTTLE, PLASTIC